Sino Biological,Inc. (SHE:301047)
China flag China · Delayed Price · Currency is CNY
60.43
+0.03 (0.05%)
At close: Apr 30, 2025, 2:57 PM CST
-31.33%
Market Cap 7.36B
Revenue (ttm) 616.62M
Net Income (ttm) 100.80M
Shares Out 121.64M
EPS (ttm) 0.80
PE Ratio 75.63
Forward PE 52.36
Dividend 1.00 (1.63%)
Ex-Dividend Date n/a
Volume 391,057
Average Volume 628,432
Open 60.50
Previous Close 60.40
Day's Range 60.43 - 61.09
52-Week Range 53.51 - 89.09
Beta 0.98
RSI 42.95
Earnings Date Apr 19, 2025

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers worldwide. It offers recombinant proteins, antibodies, cDNA clones, kits, and other reagents that are used in the areas of cancer, cardiovascular biology, cell and developmental biology, epigenetics, immunology, neuroscience, signal transduction, and stem cells. The company also provides pre-clinical production technology services for monoclonal antibody drug candidates; and custom services, such as protein production, antibody development and p... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 1,021
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301047
Full Company Profile

Financial Performance

In 2024, Sino Biological,Inc.'s revenue was 613.67 million, a decrease of -5.06% compared to the previous year's 646.39 million. Earnings were 121.93 million, a decrease of -53.13%.

Financial Statements

News

There is no news available yet.